Screening is a test to detect early disease or risk factors for disease in large numbers of apparently healthy individuals. In medicine, it is checking for disease when there are no symptoms.
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...
Join us for an insightful webinar to discuss a holistic approach to testing for TB in a clinical setting. Tuberculosis remains a global health challenge and accurate, timely diagnosis is cri...
Cell line development (CLD) is often a critical bottleneck in biopharmaceutical production, often requiring labor-intensive workflows and multiple sequential screening steps that extend time...
Accurate and timely diagnosis of inborn errors of immunity (IEI) is essential for improving patient outcomes. Flow cytometry is widely recommended for robust and sensitive IEI screening; how...
This webinar explores the evolving role of MRSA surveillance in healthcare, highlighting how molecular screening methods impact infection prevention and antimicrobial stewardship strategies....
Congenital cytomegalovirus (cCMV) is the most common infectious cause of birth defects and non-genetic hearing loss in the United States, yet it remains underdiagnosed due to the absence of...
From Discovery to Clinic: Comprehensive CRISPR Solutions for Therapeutic Development CRISPR gene editing has revolutionized the field of molecular biology, offering precise, efficient, and v...
Engineered immune cell therapies offer the promise of more tailored interventions than traditional systemic checkpoint blockades, but so far remain ineffective across the majority of clinica...
The discovery of covalent inhibitors has become a powerful strategy in drug development due to their ability to form irreversible bonds with target proteins, resulting in enhanced therapeuti...
Pharmaceutical R&D and quality control face increasing demands for speed, scalability, and regulatory compliance – yet many workflows remain manual, fragmented, and resource-intens...
Ebola virus executes its replication cycle through a tightly orchestrated sequence of events, but the host factors that govern the timing of these steps have remained poorly defined. In this...
In this webinar, learn how Sanofi is building an integrated wet and digital lab environment to accelerate large molecule research. Yves Fomekong Nanfack, Executive Director and Head of End-t...
The upcoming webinar will delve into the advanced applications of Next Generation Flow™ in the analysis of Minimal Residual Disease (MRD) in Multiple Myeloma (MM). Dr. Juan Flores-Mont...
In this webinar, Dr. Fernando Solano, Head of the Haematology Department at Hospital General Universitario Nuestra Señora del Prado, Talavera de la Reina, will discuss the implementat...
Bispecific antibodies (bsAbs) represent a versatile and increasingly important class of targeted therapeutics, designed to bind two distinct sites — either two different epitopes on th...
Join us for an in-depth webinar on quantitative chemoproteomics with TMT reagents, featuring two distinguished speakers from both academia and industry. This webinar aims to bridge the gap b...
BrainXell offers the most comprehensive portfolio of high-purity iPSC-derived human neurons and glia, sourced from control, edited and disease lines, to advance translational research and dr...
Join us for an enlightening session on the latest advancements in organoid research and drug discovery! Discover transformative applications, emerging trends, and common challenges in organo...
Antibody-drug conjugates (ADCs) are a novel class of cancer therapeutics comprised of a linker-payload conjugated to a selective monoclonal antibody targeting a tumor-associated antigen (TAA...
Tuberculosis (TB) remains a disease of global significance, causing 1.3 million deaths and 10.6 million cases of active disease worldwide each year. The World Health Organization (WHO) has i...
Join us to explore the latest advancements in pharmacogenomic (PGx) analysis with our newly launched Infinium microarrays and DRAGEN Array software. The Infinium Global Clinical Research Arr...
In 2022, there were approximately 1.4 million new cases of prostate cancer reported globally and over 397,000 deaths reported globally. PSA testing can have significant value in detecting me...
According to the CDC, in the United States, approximately 14.7% of adults have Diabetes, and another 10.8% have prediabetes. Unfortunately, as many as 8.7 million adults aged 18 years or old...
The discovery and optimization of antibodies, whether through traditional methods or with the assistance of artificial intelligence, necessitates rapid and reliable data generation. Here we...
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...
Join us for an insightful webinar to discuss a holistic approach to testing for TB in a clinical setting. Tuberculosis remains a global health challenge and accurate, timely diagnosis is cri...
Cell line development (CLD) is often a critical bottleneck in biopharmaceutical production, often requiring labor-intensive workflows and multiple sequential screening steps that extend time...
Accurate and timely diagnosis of inborn errors of immunity (IEI) is essential for improving patient outcomes. Flow cytometry is widely recommended for robust and sensitive IEI screening; how...
This webinar explores the evolving role of MRSA surveillance in healthcare, highlighting how molecular screening methods impact infection prevention and antimicrobial stewardship strategies....
Congenital cytomegalovirus (cCMV) is the most common infectious cause of birth defects and non-genetic hearing loss in the United States, yet it remains underdiagnosed due to the absence of...
From Discovery to Clinic: Comprehensive CRISPR Solutions for Therapeutic Development CRISPR gene editing has revolutionized the field of molecular biology, offering precise, efficient, and v...
Engineered immune cell therapies offer the promise of more tailored interventions than traditional systemic checkpoint blockades, but so far remain ineffective across the majority of clinica...
The discovery of covalent inhibitors has become a powerful strategy in drug development due to their ability to form irreversible bonds with target proteins, resulting in enhanced therapeuti...
Pharmaceutical R&D and quality control face increasing demands for speed, scalability, and regulatory compliance – yet many workflows remain manual, fragmented, and resource-intens...
Ebola virus executes its replication cycle through a tightly orchestrated sequence of events, but the host factors that govern the timing of these steps have remained poorly defined. In this...
In this webinar, learn how Sanofi is building an integrated wet and digital lab environment to accelerate large molecule research. Yves Fomekong Nanfack, Executive Director and Head of End-t...
The upcoming webinar will delve into the advanced applications of Next Generation Flow™ in the analysis of Minimal Residual Disease (MRD) in Multiple Myeloma (MM). Dr. Juan Flores-Mont...
In this webinar, Dr. Fernando Solano, Head of the Haematology Department at Hospital General Universitario Nuestra Señora del Prado, Talavera de la Reina, will discuss the implementat...
Bispecific antibodies (bsAbs) represent a versatile and increasingly important class of targeted therapeutics, designed to bind two distinct sites — either two different epitopes on th...
Join us for an in-depth webinar on quantitative chemoproteomics with TMT reagents, featuring two distinguished speakers from both academia and industry. This webinar aims to bridge the gap b...
BrainXell offers the most comprehensive portfolio of high-purity iPSC-derived human neurons and glia, sourced from control, edited and disease lines, to advance translational research and dr...
Join us for an enlightening session on the latest advancements in organoid research and drug discovery! Discover transformative applications, emerging trends, and common challenges in organo...
Antibody-drug conjugates (ADCs) are a novel class of cancer therapeutics comprised of a linker-payload conjugated to a selective monoclonal antibody targeting a tumor-associated antigen (TAA...
Tuberculosis (TB) remains a disease of global significance, causing 1.3 million deaths and 10.6 million cases of active disease worldwide each year. The World Health Organization (WHO) has i...
Join us to explore the latest advancements in pharmacogenomic (PGx) analysis with our newly launched Infinium microarrays and DRAGEN Array software. The Infinium Global Clinical Research Arr...
In 2022, there were approximately 1.4 million new cases of prostate cancer reported globally and over 397,000 deaths reported globally. PSA testing can have significant value in detecting me...
According to the CDC, in the United States, approximately 14.7% of adults have Diabetes, and another 10.8% have prediabetes. Unfortunately, as many as 8.7 million adults aged 18 years or old...
The discovery and optimization of antibodies, whether through traditional methods or with the assistance of artificial intelligence, necessitates rapid and reliable data generation. Here we...